Search tips
Search criteria 


Logo of gutGutView this articleSubmit a manuscriptReceive email alertsContact usBMJ
Gut. 1996 October; 39(4): 587–593.
PMCID: PMC1383274

Role of the gut in the pathophysiology of extrahepatic biliary obstruction.


BACKGROUND: Gram negative septic events are the commonest source of morbidity and mortality as a result of surgery in jaundiced patients. The large intestine provides the major source of Gram negative bacteria in mammals and is implicated in the pathogenesis of systemic endotoxaemia in obstructive jaundice. Bile salts have an important part in maintaining indigenous microecological homeostasis through their emulsifying properties. AIMS: The aim was to investigate the effects of biliary obstruction and isolated external biliary diversion on gastro-intestinal structure and caecal bacterial flora in relation to bacterial translocation. METHOD: Six groups of adult male Wistar rats were studied (no operation, sham operated, and bile duct ligated (BDL) for one and three weeks and a choledocho-vesical fistula (CDVF) for one week). At the end of the study period plasma was assayed for evidence of endotoxaemia and the animals were tested for bacterial translocation to the mesenteric lymph node complex (MLNC), liver, lungs, and spleen. Quantitative and qualitative bacteriological studies were performed on the caecal contents and segments of colon and terminal ileum were washed and prepared for histological assessment. RESULTS: Bacterial translocation was significantly increased in the BDL1 (68.8%) and BDL3 (60%) groups compared with the sham1 (6.3%), sham3 (9.1%), No operation (0%), and CDVF1 (16.7%) groups. Although translocation was more pronounced in the BDL1 group, this was almost exclusively to the MLNC compared with the more widespread translocation to other organs in the BDL3 group. The BDL3 group was the only group with significantly raised concentrations of endotoxin and anticore glycolipid. The caecal Gram negative aerobic counts were significantly increased in the BDL1 and CDVF1 groups compared with all other groups. There was evidence of structural abnormalities in the terminal ileum of rats jaundiced for three weeks, but not in the other groups. CONCLUSIONS: Biliary obstruction for one and three weeks promotes bacterial translocation although the mechanisms may be different. Absence of intralumenal bile results in a significant but self limiting increase in the Gram negative aerobic population, which may account for translocation in the early stages of biliary obstruction. As the duration of biliary obstruction increases systemic endotoxaemia is a consistent feature which, combined with factors such as immunological depression and physical disruption of gut barrier function, may promote bacterial translocation perpetuating systemic sepsis.

Full text

Full text is available as a scanned copy of the original print version. Get a printable copy (PDF file) of the complete article (1.6M), or click on a page image below to browse page by page. Links to PubMed are also available for Selected References.

Images in this article

Click on the image to see a larger version.

Selected References

These references are in PubMed. This may not be the complete list of references from this article.
  • Holman JM, Jr, Rikkers LF, Moody FG. Sepsis in the management of complicated biliary disorders. Am J Surg. 1979 Dec;138(6):809–813. [PubMed]
  • Armstrong CP, Dixon JM, Taylor TV, Davies GC. Surgical experience of deeply jaundiced patients with bile duct obstruction. Br J Surg. 1984 Mar;71(3):234–238. [PubMed]
  • Lai EC, Chu KM, Lo CY, Mok FP, Fan ST, Lo CM, Wong J. Surgery for malignant obstructive jaundice: analysis of mortality. Surgery. 1992 Nov;112(5):891–896. [PubMed]
  • Diamond T, Rowlands BJ. Endotoxaemia in obstructive jaundice. HPB Surg. 1991 Jun;4(2):81–94. [PMC free article] [PubMed]
  • Drivas G, James O, Wardle N. Study of reticuloendothelial phagocytic capacity in patients with cholestasis. Br Med J. 1976 Jun 26;1(6025):1568–1569. [PMC free article] [PubMed]
  • Clements WD, Halliday MI, McCaigue MD, Barclay RG, Rowlands BJ. Effects of extrahepatic obstructive jaundice on Kupffer cell clearance capacity. Arch Surg. 1993 Feb;128(2):200–205. [PubMed]
  • Deitch EA, Sittig K, Li M, Berg R, Specian RD. Obstructive jaundice promotes bacterial translocation from the gut. Am J Surg. 1990 Jan;159(1):79–84. [PubMed]
  • Ding JW, Andersson R, Soltesz V, Willén R, Bengmark S. Obstructive jaundice impairs reticuloendothelial function and promotes bacterial translocation in the rat. J Surg Res. 1994 Aug;57(2):238–245. [PubMed]
  • Scott BB, Barclay GR. Endotoxin-polymyxin complexes in an improved enzyme-linked immunosorbent assay for IgG antibodies in blood donor sera to gram-negative endotoxin core glycolipids. Vox Sang. 1987;52(4):272–280. [PubMed]
  • Sikora SS, Kapoor R, Pradeep R, Kapoor VK, Saxena R, Kaushik SP. Palliative surgical treatment of malignant obstructive jaundice. Eur J Surg Oncol. 1994 Oct;20(5):580–584. [PubMed]
  • Bakkevold KE, Kambestad B. Morbidity and mortality after radical and palliative pancreatic cancer surgery. Risk factors influencing the short-term results. Ann Surg. 1993 Apr;217(4):356–368. [PubMed]
  • Su CH, P'eng FK, Lui WY. Factors affecting morbidity and mortality in biliary tract surgery. World J Surg. 1992 May-Jun;16(3):536–540. [PubMed]
  • Wait RB, Kahng KU. Renal failure complicating obstructive jaundice. Am J Surg. 1989 Feb;157(2):256–263. [PubMed]
  • Hunt DR, Allison ME, Prentice CR, Blumgart LH. Endotoxemia, disturbance of coagulation, and obstructive jaundice. Am J Surg. 1982 Sep;144(3):325–329. [PubMed]
  • Grande L, Garcia-Valdecasas JC, Fuster J, Visa J, Pera C. Obstructive jaundice and wound healing. Br J Surg. 1990 Apr;77(4):440–442. [PubMed]
  • Wilkinson SP, Moodie H, Stamatakis JD, Kakkar VV, Williams R. Endotoxaemia and renal failure in cirrhosis and obstructive jaundice. Br Med J. 1976 Dec 11;2(6049):1415–1418. [PMC free article] [PubMed]
  • Wardle EN, Wright NA. Endotoxin and acute renal failure associated with obstructive jaundice. Br Med J. 1970 Nov 21;4(5733):472–474. [PMC free article] [PubMed]
  • Greve JW, Gouma DJ, Soeters PB, Buurman WA. Suppression of cellular immunity in obstructive jaundice is caused by endotoxins: a study with germ-free rats. Gastroenterology. 1990 Feb;98(2):478–485. [PubMed]
  • Bemelmans MH, Gouma DJ, Greve JW, Buurman WA. Cytokines tumor necrosis factor and interleukin-6 in experimental biliary obstruction in mice. Hepatology. 1992 Jun;15(6):1132–1136. [PubMed]
  • Beutler B, Cerami A. Cachectin: more than a tumor necrosis factor. N Engl J Med. 1987 Feb 12;316(7):379–385. [PubMed]
  • Molloy RG, Mannick JA, Rodrick ML. Cytokines, sepsis and immunomodulation. Br J Surg. 1993 Mar;80(3):289–297. [PubMed]
  • Deitch EA. Simple intestinal obstruction causes bacterial translocation in man. Arch Surg. 1989 Jun;124(6):699–701. [PubMed]
  • Deitch EA. Intestinal permeability is increased in burn patients shortly after injury. Surgery. 1990 Apr;107(4):411–416. [PubMed]
  • Baker JW, Deitch EA, Li M, Berg RD, Specian RD. Hemorrhagic shock induces bacterial translocation from the gut. J Trauma. 1988 Jul;28(7):896–906. [PubMed]
  • Deitch EA, Berg R, Specian R. Endotoxin promotes the translocation of bacteria from the gut. Arch Surg. 1987 Feb;122(2):185–190. [PubMed]
  • Li M, Specian RD, Berg RD, Deitch EA. Effects of protein malnutrition and endotoxin on the intestinal mucosal barrier to the translocation of indigenous flora in mice. JPEN J Parenter Enteral Nutr. 1989 Nov-Dec;13(6):572–578. [PubMed]
  • Berg RD, Wommack E, Deitch EA. Immunosuppression and intestinal bacterial overgrowth synergistically promote bacterial translocation. Arch Surg. 1988 Nov;123(11):1359–1364. [PubMed]
  • Bergesen O, Schjønsby H, Andersen KJ, Schjerven L. Intestinal epithelial function and villus surface area in rats with bile fistulae. Scand J Gastroenterol. 1987 Aug;22(6):731–736. [PubMed]
  • Xu D, Qi L, Guillory D, Cruz N, Berg R, Deitch EA. Mechanisms of endotoxin-induced intestinal injury in a hyperdynamic model of sepsis. J Trauma. 1993 May;34(5):676–683. [PubMed]
  • Deitch EA, Specian RD, Berg RD. Endotoxin-induced bacterial translocation and mucosal permeability: role of xanthine oxidase, complement activation, and macrophage products. Crit Care Med. 1991 Jun;19(6):785–791. [PubMed]
  • Burke V, Stone DE, Beaman J, Gracey M. Effects of biliary diversion on intestinal microflora in the rat. J Med Microbiol. 1977 May;10(2):241–244. [PubMed]
  • Slocum MM, Sittig KM, Specian RD, Deitch EA. Absence of intestinal bile promotes bacterial translocation. Am Surg. 1992 May;58(5):305–310. [PubMed]
  • Vane DW, Redlich P, Weber T, Leapman S, Siddiqui AR, Grosfeld JL. Impaired immune function in obstructive jaundice. J Surg Res. 1988 Sep;45(3):287–293. [PubMed]
  • Pinto M, Kaplun A. Immune status in mice with experimental biliary obstruction. Clin Immunol Immunopathol. 1980 Aug;16(4):396–405. [PubMed]
  • Roughneen PT, Drath DB, Kulkarni AD, Rowlands BJ. Impaired nonspecific cellular immunity in experimental cholestasis. Ann Surg. 1987 Nov;206(5):578–582. [PubMed]
  • Feduccia TD, Scott-Conner CE, Grogan JB. Profound suppression of lymphocyte function in early biliary obstruction. Am J Med Sci. 1988 Jul;296(1):39–44. [PubMed]
  • Greve JW, Gouma DJ, Soeters PB, Buurman WA. Suppression of cellular immunity in obstructive jaundice is caused by endotoxins: a study with germ-free rats. Gastroenterology. 1990 Feb;98(2):478–485. [PubMed]
  • Gautreaux MD, Deitch EA, Berg RD. T lymphocytes in host defense against bacterial translocation from the gastrointestinal tract. Infect Immun. 1994 Jul;62(7):2874–2884. [PMC free article] [PubMed]
  • Deitch EA, Xu DZ, Qi L, Berg RD. Bacterial translocation from the gut impairs systemic immunity. Surgery. 1991 Mar;109(3 Pt 1):269–276. [PubMed]
  • Megison SM, Dunn CW, Horton JW, Chao H. Effects of relief of biliary obstruction on mononuclear phagocyte system function and cell mediated immunity. Br J Surg. 1991 May;78(5):568–571. [PubMed]
  • Scott-Conner CE, Grogan JB. The pathophysiology of biliary obstruction and its effect on phagocytic and immune function. J Surg Res. 1994 Aug;57(2):316–336. [PubMed]
  • Wells CL, Maddaus MA, Simmons RL. Proposed mechanisms for the translocation of intestinal bacteria. Rev Infect Dis. 1988 Sep-Oct;10(5):958–979. [PubMed]
  • Nieuwenhuijzen GA, Haskel Y, Lu Q, Berg RD, van Rooijen N, Goris RJ, Deitch EA. Macrophage elimination increases bacterial translocation and gut-origin septicemia but attenuates symptoms and mortality rate in a model of systemic inflammation. Ann Surg. 1993 Dec;218(6):791–799. [PubMed]
  • Iwanaga S, Morita T, Harada T, Nakamura S, Niwa M, Takada K, Kimura T, Sakakibara S. Chromogenic substrates for horseshoe crab clotting enzyme. Its application for the assay of bacterial endotoxins. Haemostasis. 1978;7(2-3):183–188. [PubMed]
  • Kocsár LT, Bertók L, Várterész V. Effect of bile acids on the intestinal absorption of endotoxin in rats. J Bacteriol. 1969 Oct;100(1):220–223. [PMC free article] [PubMed]
  • Cebra JJ, Kamat R, Gearhart P, Robertson SM, Tseng J. The secretory IgA system of the gut. Ciba Found Symp. 1977 Apr 26;(46):5–28. [PubMed]
  • Spaeth G, Gottwald T, Specian RD, Mainous MR, Berg RD, Deitch EA. Secretory immunoglobulin A, intestinal mucin, and mucosal permeability in nutritionally induced bacterial translocation in rats. Ann Surg. 1994 Dec;220(6):798–808. [PubMed]
  • van der Waaij D. Colonization resistance of the digestive tract--mechanism and clinical consequences. Nahrung. 1987;31(5-6):507–517. [PubMed]
  • McNeil NI, Cummings JH, James WP. Short chain fatty acid absorption by the human large intestine. Gut. 1978 Sep;19(9):819–822. [PMC free article] [PubMed]
  • Cruz N, Lu Q, Alvarez X, Deitch EA. Bacterial translocation is bacterial species dependent: results using the human Caco-2 intestinal cell line. J Trauma. 1994 May;36(5):612–616. [PubMed]
  • Katouli M, Bark T, Ljungqvist O, Svenberg T, Möllby R. Composition and diversity of intestinal coliform flora influence bacterial translocation in rats after hemorrhagic stress. Infect Immun. 1994 Nov;62(11):4768–4774. [PMC free article] [PubMed]
  • Katz S, Grosfeld JL, Gross K, Plager DA, Ross D, Rosenthal RS, Hull M, Weber TR. Impaired bacterial clearance and trapping in obstructive jaundice. Ann Surg. 1984 Jan;199(1):14–20. [PubMed]
  • Floch MH, Gershengoren W, Elliott S, Spiro HM. Bile acid inhibition of the intestinal microflora--a function for simple bile acids? Gastroenterology. 1971 Aug;61(2):228–233. [PubMed]
  • Williams RC, Showalter R, Kern F., Jr In vivo effect of bile salts and cholestyramine on intestinal anaerobic bacteria. Gastroenterology. 1975 Aug;69(2):483–491. [PubMed]
  • Höckerstedt K. Liver transplantation today. Scand J Gastroenterol. 1990 Jan;25(1):1–10. [PubMed]
  • Cahill CJ. Prevention of postoperative renal failure in patients with obstructive jaundice--the role of bile salts. Br J Surg. 1983 Oct;70(10):590–595. [PubMed]
  • Pain JA, Bailey ME. Prevention of endotoxaemia in obstructive jaundice--a comparative study of bile salts. HPB Surg. 1988 Sep;1(1):21–27. [PMC free article] [PubMed]
  • Ding JW, Andersson R, Soltesz V, Willén R, Bengmark S. The role of bile and bile acids in bacterial translocation in obstructive jaundice in rats. Eur Surg Res. 1993 Jan-Feb;25(1):11–19. [PubMed]

Articles from Gut are provided here courtesy of BMJ Publishing Group